19 (7):582-590 Corresponding authors: Suowen Xu, PhD or Jianping Weng, MD, PhD, E-mail: sxu1984
Many are now FDA-approved for chronic weight management
In this episode and the accompanying feature, we invited a patient with lived experience to see if this worked in real life while discussing the potential mechanisms with a researcher.
Such detailed understanding of its mechanism underscores the importance of Retatrutide in addressing obesity from multiple fronts
For example, some people taking GLP-1 medications have reported digestive tract side effects such as nausea, vomiting, and diarrhea
New guidelines for GLP-1 therapy and obesity treatment Evidence-based nutritional and lifestyle strategies play a pivotal role to address key challenges around GLP-1 treatment of obesity, making clinicians more effective in advancing their patients' health